Ketamine for Anxiety and Depression: What to Expect
· Updated November 2026 · Aazaz Haq, MD
Anxiety and depression often travel together. Many of the people I see with treatment-resistant depression also describe constant worry, restlessness or dread. So a common question is whether ketamine helps with the anxiety too.
The short answer
Ketamine has its strongest evidence in depression, including depression that has not responded to several medications, and it often eases anxious symptoms along with low mood. Evidence for anxiety alone is smaller. We give it by IV or IM injection in a monitored setting, as part of a broader treatment plan.
What we know
Ketamine's strongest evidence is for depression, including depression that has not responded to several antidepressants. In randomized trials, a meaningful share of people improved within a day of an infusion, and a series of treatments can extend that benefit.
For anxiety, the evidence is smaller. In trials of depression, ketamine often eases anxious symptoms along with low mood. Small studies in people with treatment-resistant anxiety disorders have also shown reductions in anxiety, but these were early studies with few participants. Ketamine is not FDA-approved for anxiety.
In practice, I consider ketamine for anxiety mainly when it comes with depression that has not responded to standard treatment.
How we give it
We offer ketamine by IV infusion or by intramuscular (IM) injection. Both deliver the same medicine. An IM injection avoids an IV line; an IV infusion is given slowly and can be adjusted during the session. Your clinician will help you choose.
Some people with anxiety worry about the dissociative feeling during treatment. We talk through what to expect beforehand, keep the room calm, stay with you, and have medicine for anxiety or nausea on hand. For some anxious patients, Spravato, which tends to feel less intense, is a better fit.
Who leads treatment
Treatment plans at our clinic are made by our clinicians: psychiatrists and advanced practice clinicians, under my supervision as medical director. I have spent my career treating complex and treatment-resistant depression, and every ketamine plan starts with a full psychiatric evaluation.
What treatment involves
- Usually two treatments a week for four weeks, then spaced out for people who are doing well.
- Blood pressure checks before and during each session.
- Monitoring until you are ready to go home with a driver.
- Regular depression and anxiety measurements to see whether it is working.
Ketamine works best as part of a broader plan. Therapy, sleep, exercise and reconnecting with people and activities all help hold the gains.
Cost
IV and IM ketamine are self-pay at $400 per treatment, with payment plans. Spravato is covered by most insurance plans.
If anxiety and depression have not improved enough with standard treatment, request a consultation call to talk through your options.
Questions I hear often
Will ketamine make my anxiety worse?
The dissociative feeling during treatment can be uncomfortable for anxious people, especially the first time. We prepare you, stay nearby, and have medicine available if needed. Most people find later sessions easier. Over the following days, anxiety often eases along with depression.
Can I keep taking my anxiety medication?
Usually, yes, though some medications, such as high doses of benzodiazepines, may reduce ketamine's effect. We review your medications during the evaluation and make a plan with you.
Is ketamine a long-term solution?
For some people it is part of long-term care, with maintenance treatments spaced as far apart as possible. For others, a course helps them get back on their feet, and therapy and other treatments carry them forward. We discuss maintenance openly from the start.
Other options for anxiety with depression
Ketamine is one option among several. TMS is FDA-cleared for depression, and some devices are cleared for depression with anxiety symptoms. Medication adjustments, sleep treatment and therapy approaches such as CBT all have strong evidence. The right plan depends on which symptoms are driving the most suffering, and that is what we sort out together during the evaluation.
References
- Murrough JW, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013. PubMed
- Glue P, et al. Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders. J Psychopharmacol. 2017. PubMed